JS016 is said to be the first SARS-CoV-2 neutralising antibody to advance into trials in China. Credit: Visuals3D from Pixabay.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more
